Jamieson Wellness (TSE:JWEL - Get Free Report) had its price target hoisted by equities research analysts at TD Securities from C$40.00 to C$42.00 in a research report issued on Friday,BayStreet.CA reports. The firm currently has a "buy" rating on the stock. TD Securities' price objective suggests a potential upside of 17.38% from the company's previous close.
JWEL has been the topic of several other reports. Royal Bank of Canada increased their price objective on shares of Jamieson Wellness from C$32.00 to C$37.00 in a report on Friday, August 9th. Canaccord Genuity Group increased their price target on shares of Jamieson Wellness from C$32.50 to C$36.25 in a research note on Friday, August 9th. Finally, BMO Capital Markets boosted their price objective on shares of Jamieson Wellness from C$35.00 to C$42.00 in a research note on Friday, August 9th.
Check Out Our Latest Report on JWEL
Jamieson Wellness Price Performance
TSE:JWEL traded up C$2.10 during trading hours on Friday, reaching C$35.78. 65,761 shares of the company traded hands, compared to its average volume of 60,840. The company has a debt-to-equity ratio of 92.76, a current ratio of 3.21 and a quick ratio of 1.08. The firm's 50-day moving average is C$33.86 and its 200-day moving average is C$30.53. The stock has a market cap of C$1.48 billion, a P/E ratio of 41.30 and a beta of 0.63. Jamieson Wellness has a 1-year low of C$23.98 and a 1-year high of C$35.90.
Insider Transactions at Jamieson Wellness
In other news, Director Michael Al Pilato sold 24,465 shares of the firm's stock in a transaction dated Friday, September 13th. The shares were sold at an average price of C$33.41, for a total value of C$817,380.54. In related news, Director Michael Al Pilato sold 24,465 shares of the company's stock in a transaction on Friday, September 13th. The stock was sold at an average price of C$33.41, for a total transaction of C$817,380.54. Also, Senior Officer Regan Stewart sold 8,732 shares of Jamieson Wellness stock in a transaction dated Monday, August 26th. The shares were sold at an average price of C$31.65, for a total transaction of C$276,373.04. In the last 90 days, insiders sold 72,058 shares of company stock valued at $2,307,317. Insiders own 0.26% of the company's stock.
About Jamieson Wellness
(
Get Free Report)
Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Jamieson Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jamieson Wellness wasn't on the list.
While Jamieson Wellness currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.